{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:23:03Z","timestamp":1778494983470,"version":"3.51.4"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016967","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T23:43:07Z","timestamp":1298072587000},"page":"e16967","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Localized Delivery of Interferon-\u03b2 by Lactobacillus Exacerbates Experimental Colitis"],"prefix":"10.1371","volume":"6","author":[{"given":"Adelle P.","family":"McFarland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Savan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagie","family":"Wagage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustina","family":"Addison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthika","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Karwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tri","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling.","volume":"5","author":"LC Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref2","first-page":"pe70","article-title":"Type I interferons as anti-inflammatory mediators.","volume":"416","author":"EN Benveniste","year":"2007","journal-title":"Sci STKE 2007"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.antiviral.2006.03.006","article-title":"Anti-inflammatory properties of Type I interferons.","volume":"71","author":"A Billiau","year":"2006","journal-title":"Antiviral Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1186\/ar1165","article-title":"Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis.","volume":"6","author":"HJ van","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A","article-title":"Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.","volume":"42","author":"KA Triantaphyllopoulos","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1182\/blood-2005-07-3058","article-title":"Interferons limit inflammatory responses by induction of tristetraprolin.","volume":"107","author":"I Sauer","year":"2006","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"11216","DOI":"10.1074\/jbc.M901229200","article-title":"Tristetraprolin mediates interferon-gamma mRNA decay.","volume":"284","author":"RL Ogilvie","year":"2009","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1073\/pnas.89.19.9049","article-title":"Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.","volume":"89","author":"IC Oliveira","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.177.2.822","article-title":"Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells.","volume":"177","author":"S Nozell","year":"2006","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0165-5728(97)00114-8","article-title":"Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study.","volume":"79","author":"E Corsini","year":"1997","journal-title":"J Neuroimmunol"},{"key":"ref11","first-page":"S47","article-title":"Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.","volume":"6","author":"M Trojano","year":"2000","journal-title":"J Neurovirol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.410400606","article-title":"Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.","volume":"40","author":"D Leppert","year":"1996","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ana.410400607","article-title":"Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.","volume":"40","author":"O Stuve","year":"1996","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","article-title":"Th17 Cells and autoimmune encephalomyelitis (EAE\/MS).","volume":"57","author":"T Aranami","year":"2008","journal-title":"Allergol Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.","volume":"8","author":"C Lock","year":"2002","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.","volume":"172","author":"JS Tzartos","year":"2008","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.","volume":"65","author":"L Durelli","year":"2009","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1172\/JCI33342","article-title":"The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.","volume":"118","author":"B Guo","year":"2008","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.4049\/jimmunol.0803227","article-title":"IFN-beta inhibits human Th17 cell differentiation.","volume":"183","author":"VS Ramgolam","year":"2009","journal-title":"J Immunol"},{"key":"ref20","first-page":"1362","article-title":"[A case study: interferon-beta-induced remission of ulcerative colitis in a patient with type C chronic hepatitis].","volume":"105","author":"T Miike","year":"2008","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1046\/j.1365-2036.2002.01264.x","article-title":"Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial.","volume":"16","author":"E Musch","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1055\/s-2007-963378","article-title":"Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta\u2014an open long-term trial.","volume":"45","author":"E Musch","year":"2007","journal-title":"Z Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/ibd.21242","article-title":"Case series: Ulcerative colitis, multiple sclerosis, and interferon-beta 1a.","volume":"16","author":"S Rodrigues","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"ref24","first-page":"816","article-title":"[Crohn&apos;s disease during the course of multiple sclerosis: role of interferon-beta therapy].","volume":"30","author":"M Samson","year":"2009","journal-title":"Rev Med Interne"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.3748\/wjg.v13.i26.3638","article-title":"Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.","volume":"13","author":"E Schott","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref26","first-page":"438","article-title":"Acute ulcerative colitis during successful interferon\/ribavirin treatment for chronic hepatitis.","volume":"54","author":"R Sprenger","year":"2005","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2006.105197","article-title":"A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.","volume":"55","author":"T Watanabe","year":"2006","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease.","volume":"52","author":"S Fujino","year":"2003","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria.","volume":"139","author":"II Ivanov","year":"2009","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.","volume":"116","author":"D Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI22996","article-title":"Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.","volume":"115","author":"K Katakura","year":"2005","journal-title":"J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.imbio.2008.07.022","article-title":"Interferon-alpha controls IL-17 expression in vitro and in vivo.","volume":"213","author":"AR Moschen","year":"2008","journal-title":"Immunobiology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.gastro.2007.06.018","article-title":"Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.","volume":"133","author":"B Foligne","year":"2007","journal-title":"Gastroenterology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.","volume":"289","author":"L Steidler","year":"2000","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/mi.2009.116","article-title":"Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis.","volume":"3","author":"K Vandenbroucke","year":"2010","journal-title":"Mucosal Immunol"},{"key":"ref36","first-page":"303","article-title":"Generation of macrophage cell line from fresh bone marrow cells with a myc\/raf recombinant retrovirus.","volume":"10","author":"E Blasi","year":"1989","journal-title":"Cancer Biochem Biophys"},{"key":"ref37","article-title":"Construction of vectors for inducible and constitutive gene expression in Lactobacillus.","author":"T Duong","year":"2010","journal-title":"Microbial Biotech, no"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor.","volume":"176","author":"K Inaba","year":"1992","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.immuni.2009.08.010","article-title":"Origin of the lamina propria dendritic cell network.","volume":"31","author":"M Bogunovic","year":"2009","journal-title":"Immunity"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.0708469104","article-title":"Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells.","volume":"104","author":"K Abe","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20090247","article-title":"Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant.","volume":"206","author":"MP Longhi","year":"2009","journal-title":"J Exp Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/107999004322813372","article-title":"The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.","volume":"24","author":"SL Pogue","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1189\/jlb.1205742","article-title":"Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.","volume":"79","author":"M Severa","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.gastro.2003.11.019","article-title":"Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.","volume":"126","author":"D Rachmilewitz","year":"2004","journal-title":"Gastroenterology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature07240","article-title":"ATP drives lamina propria T(H)17 cell differentiation.","volume":"455","author":"K Atarashi","year":"2008","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2009.08.015","article-title":"Before they were gut dendritic cells.","volume":"31","author":"M Rescigno","year":"2009","journal-title":"Immunity"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.immuni.2010.03.017","article-title":"E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis.","volume":"32","author":"KR Siddiqui","year":"2010","journal-title":"Immunity"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni.1622","article-title":"Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5.","volume":"9","author":"S Uematsu","year":"2008","journal-title":"Nat Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/138945008784221125","article-title":"The pathogenic role of intestinal flora in IBD and colon cancer.","volume":"9","author":"M Rescigno","year":"2008","journal-title":"Curr Drug Targets"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/mi.2008.52","article-title":"Intestinal microflora and immunoregulation.","volume":"1","author":"M Boirivant","year":"2008","journal-title":"Mucosal Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.immuni.2009.09.001","article-title":"The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses.","volume":"31","author":"W Strober","year":"2009","journal-title":"Immunity"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","article-title":"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn&apos;s disease.","volume":"4","author":"H Braat","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2249.2003.02288.x","article-title":"Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis.","volume":"134","author":"F Obermeier","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2567.2010.03301.x","article-title":"Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism.","volume":"131","author":"G Weiss","year":"2010","journal-title":"Immunology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/eji.200939233","article-title":"Type I IFN regulate DC turnover in vivo.","volume":"39","author":"F Mattei","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation.","volume":"99","author":"M Montoya","year":"2002","journal-title":"Blood"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/mi.2008.43","article-title":"CD103+ GALT DCs promote Foxp3+ regulatory T cells.","volume":"1","author":"KR Siddiqui","year":"2008","journal-title":"Mucosal Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20051100","article-title":"Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.","volume":"202","author":"B Johansson-Lindbom","year":"2005","journal-title":"J Exp Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.0105-2896.2009.00874.x","article-title":"Development and functional specialization of CD103+ dendritic cells.","volume":"234","author":"ML del Rio","year":"2010","journal-title":"Immunol Rev"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.20040662","article-title":"Essential role for CD103 in the T cell-mediated regulation of experimental colitis.","volume":"202","author":"O Annacker","year":"2005","journal-title":"J Exp Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1074\/jbc.M109.071498","article-title":"Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.","volume":"285","author":"S Bhattacharya","year":"2010","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/emboj\/cdg038","article-title":"The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.","volume":"22","author":"J Ragimbeau","year":"2003","journal-title":"EMBO J"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/MCB.26.5.1888-1897.2006","article-title":"Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.","volume":"26","author":"DA Jaitin","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.1998.0105","article-title":"Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.","volume":"255","author":"D Russell-Harde","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1016\/S0021-9258(18)33444-6","article-title":"Interaction of interferon with cellular receptors. Internalization and degradation of cell-bound interferon.","volume":"257","author":"AA Branca","year":"1982","journal-title":"J Biol Chem"},{"key":"ref66","article-title":"Suppression of inflammation in ulcerative colitis by interferon-{beta}-1a is accompanied by inhibition of IL-13 production.","author":"PJ Mannon","year":"2010"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/eji.1830271026","article-title":"Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors.","volume":"27","author":"BL McRae","year":"1997","journal-title":"Eur J Immunol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/cyto.1997.0270","article-title":"Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha.","volume":"10","author":"A Kaser","year":"1998","journal-title":"Cytokine"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.gastro.2005.05.002","article-title":"Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.","volume":"129","author":"F Heller","year":"2005","journal-title":"Gastroenterology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.","volume":"113","author":"IJ Fuss","year":"2004","journal-title":"J Clin Invest"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T04:38:41Z","timestamp":1637296721000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016967"}},"subtitle":[],"editor":[{"given":"Jacques","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016967","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}